A significant trend from 2018 onwards across the globe was the desire of large Pharmaceutical companies to become more Agile. This included companies such as Roche, GSK and Novartis who invested heavily in training for their people to help them better manage the complex work they carried out.
TheScrumMaster.co.uk worked with all of these organisations. For GSK, we provided a mix of private and public courses.
The timing of this was fortuitous, with the arrival of Coronavirus/COVID-19 in 2020. I hope the greater agility these organisations have achieved so far will enable them to deliver vaccines and testing solutions faster than may otherwise have been possible.
The trend that the big Pharma companies were following is part of the global movement for organisations as a whole to seek greater agility or to become ‘Agile’.
The world is becoming an ever more complex place. Change is affecting industries that remained relatively static for much of their history. Technology is changing, customer demand is changing. Unexpected and volatile events are becoming the norm. The very nature of societies and economies are shifting before our eyes. The level of change and uncertainty around us at an unprecedented level. Predicting what will happen next is impossible.
Organisations have to adapt to this changing landscape in order to survive. As a result, they are recognising the need to work in a more agile way that allows them to keep maximum options open and adapt and change direction when needed with the lowest possible risk.
You can learn more about GSK’s move towards agility here:
—https://www.forbes.com/sites/peterhigh/2019/11/04/gsk-digital-and-tech-chief-drives-innovation-across-the-company/?sh=31868801ae0d
— https://www.marketingweek.com/gsk-take-on-direct-to-consumer-brands/
If you need help with Scrum & Agile then we can help you. Contact us at TheScrumMaster.co.uk to find out more.